TABLE 3.
Effects of opioid receptor antagonists on tonic luteinizing hormone (LH) secretion in female mammals.
Antagonists | Receptors | Treatment routes | Effects | Species | Ovarian states | References |
Naloxone | μ- > κ- >> δ- | i.v. | Stimulatory | Human | Late follicular phase | Quigley and Yen, 1980 |
i.v. | Stimulatory | Human | Mid-luteal phase | Quigley and Yen, 1980 | ||
i.v. | No effect | Human | Early follicular phase | Quigley and Yen, 1980 | ||
i.v. | Stimulatory | Rhesus monkey | Luteal phase | Van Vugt et al., 1983 | ||
i.v. | No effect | Rhesus monkey | Follicular phase | Van Vugt et al., 1983 | ||
s.c. | Stimulatory | Rat | Ovary-intact | Petraglia et al., 1984 | ||
s.c. | No effect | Rat | OVX | Petraglia et al., 1984 | ||
i.v. | Stimulatory | Sheep | Luteal phase | Malven et al., 1984 | ||
i.v. | No effect | Sheep | Non-luteal phase | Malven et al., 1984 | ||
i.v. | Stimulatory | Sheep | Early and mid-luteal phase | Brooks et al., 1986 | ||
i.v. | No effect | Sheep | Late-luteal phase | Brooks et al., 1986 | ||
i.v. | No effect | Human | Post-menopausal | Reid et al., 1983 | ||
3V | Stimulatory | Rat | Pregnant | Gallo, 1990 | ||
MBH, POA | Stimulatory | Sheep | Luteal phase | Goodman et al., 2004 | ||
WIN44,441-3 | κ- | i.v. | Stimulatory | Sheep | Luteal phase | Whisnant and Goodman, 1988 |
i.v. | No effect | Sheep | Follicular phase | Whisnant and Goodman, 1988 | ||
i.v. | Stimulatory | Sheep | Luteal phase | Yang et al., 1988 | ||
nor-BNI | κ- | 3V | Stimulatory | Rat | Pregnant | Gallo, 1990 |
3V | Stimulatory | Rat | OVX + low E21 | Mostari et al., 2013 | ||
3V | No effect | Rat | OVX | Mostari et al., 2013 | ||
MBH, POA | Stimulatory | Sheep | Luteal phase | Goodman et al., 2004 | ||
PF-4455242 | κ- | i.v., s.c. | Stimulatory | Goat | OVX + low E22 | Sasaki et al., 2019 |
Naloxonazine | μ- | POA | Stimulatory | Sheep | Luteal phase | Goodman et al., 2004 |
MBH | No effect | Sheep | Luteal phase | Goodman et al., 2004 | ||
ICI 174864 | δ- | 3V | No effect | Rat | Pregnant | Gallo, 1990 |
Naltrindole | δ- | MBH, POA | No effect | Sheep | Luteal phase | Goodman et al., 2004 |
nor-BNI, nor-binaltorphimine.
1Ovariectomized (OVX) rats treated with a diestrous level of E2.
2OVX goats treated with a luteal phase level of E2.